CIK 0001196298
- Non-accelerated filer
- Smaller reporting company
NEPHROS INC
Sign in to watch- Ticker
- NEPH
- Exchange
- Nasdaq
- Industry
- Surgical & Medical Instruments & Apparatus
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 133971809
- Phone
- +1 201-343-5202
- Business address
- 380 LACKAWANNA PLACE, SOUTH ORANGE, NJ, 07079
- 4 Derivatives Options or other derivatives
- 3 Insider Initial Statement of Ownership
- 4 Option exercise Chief Financial Officer acquired 33,333 shares (option exercise)
- 4 Option exercise President and CEO acquired 40,000 shares (option exercise)
- 4 Open-market buy President and CEO bought 79,000 shares at $0.45 ($35,550)
- 4 Open-market buy Chief Financial Officer bought 80,000 shares at $0.45 ($36,000)
- 4 Open-market buy Chief Financial Officer bought 5,000 shares at $0.48 ($2,375)
- 4/A Grant or award Director acquired 73,864 shares (grant or award)
- 4 Derivatives Options or other derivatives
- 4 Grant or award Director acquired 73,864 shares (grant or award)
- 4 Grant or award Director acquired 73,864 shares (grant or award)
- 4 Grant or award Director acquired 113,636 shares (grant or award)
- 4 Grant or award Director acquired 73,864 shares (grant or award)
- 4 Grant or award Chief Financial Officer acquired 120,417 shares (grant or award)
- 4 Grant or award President and CEO acquired 180,000 shares (grant or award)
- 4 Open-market buy Chief Financial Officer bought 18,333 shares at $0.50 ($9,167)
- 4 Open-market buy President and CEO bought 29,580 shares at an average $0.24 ($7,189)
- 4 Open-market buy Chief Financial Officer bought 10,000 shares at an average $0.27 ($2,712)
- 4 Open-market buy President and CEO bought 4,000 shares at $0.25 ($1,000)
- 4 Open-market buy President and CEO bought 70,000 shares at $0.26 ($18,200)
Page 7 of 17 · 332 filings